Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Hidradenitis suppurativa responding to treatment with infliximab.

Lasocki A, Sinclair R, Foley P, Saunders H.

Australas J Dermatol. 2010 Aug;51(3):186-90. doi: 10.1111/j.1440-0960.2010.00623.x.

PMID:
20695857
2.

Long-term efficacy of a single course of infliximab in hidradenitis suppurativa.

Mekkes JR, Bos JD.

Br J Dermatol. 2008 Feb;158(2):370-4.

PMID:
18047504
3.

Infliximab for hidradenitis suppurativa.

Sullivan TP, Welsh E, Kerdel FA, Burdick AE, Kirsner RS.

Br J Dermatol. 2003 Nov;149(5):1046-9.

PMID:
14632813
4.

Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients.

Fardet L, Dupuy A, Kerob D, Levy A, Allez M, Begon E, Bachelez H, Morel P, Lebbé C.

J Am Acad Dermatol. 2007 Apr;56(4):624-8.

PMID:
17240478
5.

Infliximab for the treatment of hidradenitis suppurativa.

Fernández-Vozmediano JM, Armario-Hita JC.

Dermatology. 2007;215(1):41-4.

PMID:
17587838
6.

Etanercept: effective in the management of hidradenitis suppurativa.

Cusack C, Buckley C.

Br J Dermatol. 2006 Apr;154(4):726-9.

PMID:
16536817
7.

Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.

Rosi YL, Lowe L, Kang S.

J Dermatolog Treat. 2005 Feb;16(1):58-61.

PMID:
15897171
8.

Variable response of hidradenitis suppurativa to infliximab in four patients.

Usmani N, Clayton TH, Everett S, Goodfield MD.

Clin Exp Dermatol. 2007 Mar;32(2):204-5. No abstract available.

PMID:
17342798
9.

Long-term infliximab for severe hidradenitis suppurativa.

Thielen AM, Barde C, Saurat JH.

Br J Dermatol. 2006 Nov;155(5):1105-7. No abstract available.

PMID:
17034567
10.

Long-term efficacy of infliximab in hidradenitis suppurativa.

Paradela S, Rodríguez-Lojo R, Fernández-Torres R, Arévalo P, Fonseca E.

J Dermatolog Treat. 2012 Aug;23(4):278-83. doi: 10.3109/09546634.2012.683767.

PMID:
22482700
11.

Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa.

van Rappard DC, Leenarts MF, Meijerink-van 't Oost L, Mekkes JR.

J Dermatolog Treat. 2012 Aug;23(4):284-9. doi: 10.3109/09546634.2011.571657.

PMID:
21756155
12.

Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient.

Katsanos KH, Christodoulou DK, Tsianos EV.

Am J Gastroenterol. 2002 Aug;97(8):2155-6. No abstract available.

PMID:
12190206
13.

Severe hidradenitis suppurativa treated with infliximab infusion.

Adams DR, Gordon KB, Devenyi AG, Ioffreda MD.

Arch Dermatol. 2003 Dec;139(12):1540-2. No abstract available.

PMID:
14676068
14.

[Hidradenitis suppurativa. Response to treatment with infliximab].

Pedraz J, Daudén E, Pérez-Gala S, Goiriz-Valdés R, Fernández-Peñas P, García-Diez A.

Actas Dermosifiliogr. 2007 Jun;98(5):325-31. Spanish.

PMID:
17555675
15.

A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.

Poulalhon N, Begon E, Lebbé C, Lioté F, Lahfa M, Bengoufa D, Morel P, Dubertret L, Bachelez H.

Br J Dermatol. 2007 Feb;156(2):329-36.

PMID:
17223874
16.

Efficacy and tolerance of prolonged infliximab treatment of moderate-to-severe forms of hidradenitis suppurativa.

Lesage C, Adnot-Desanlis L, Perceau G, Bonnet M, Palot JP, Bernard P, Reguiaï Z.

Eur J Dermatol. 2012 Sep-Oct;22(5):640-4. doi: 10.1684/ejd.2012.1795.

PMID:
22759562
17.

Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.

Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S.

Dig Liver Dis. 2004 May;36(5):342-7.

PMID:
15191204
18.

Infliximab in treatment of Crohn's disease: the Milan experience.

Ardizzone S, Colombo E, Maconi G, Bollani S, Manzionna G, Petrone MC, Bianchi Porro G.

Dig Liver Dis. 2002 Jun;34(6):411-8.

PMID:
12132788
19.

Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.

Reich K, Nestle FO, Papp K, Ortonne JP, Wu Y, Bala M, Evans R, Guzzo C, Li S, Dooley LT, Griffiths CE.

Br J Dermatol. 2006 Jun;154(6):1161-8.

PMID:
16704649
20.

Infliximab in the surgical management of complex fistulating anal Crohn's disease.

Talbot C, Sagar PM, Johnston MJ, Finan PJ, Burke D.

Colorectal Dis. 2005 Mar;7(2):164-8.

PMID:
15720356

Supplemental Content

Support Center